| |
|
|
| |
|
EDITORIAL ACTIVITIES
|
|
1991 THE
HYPERTRIGLYCERIDEMIAS: RISK AND MANAGEMENT Position Paper. HYPERTRIGLYCERIDEMIAS:
RISK AND MANAGEMENT Position Paper.
1992 COSA
FARE NELL'IPERTESO ANZIANO LOMEFLOXACINA
PROFILO FARMACOLOGICO E CLINICO LOMEFLOXACINA
PROFILO FARMACOLOGICO E CLINICO LOMEFLOXACINA
PRINCIPALI DATI FARMACOLOGICI E CLINICI DI UN NUOVO CHEMIO-ANTIBIOTICO SURFATTANTE:
PATOLOGIA SECRETORIA E ACEBROFILLINA GROWTH
FACTORS OF THE VASCULAR AND NERVOUS SYSTEMS:
Functional Characterization and Biotechnology SUCRALFATO
NUOVA FORMULAZIONE GEL PAROXETINA
PROFILO FARMACOLOGICO E CLINICO LO
SCOMPENSO CARDIACO
1993 DRUGS
AND THE LIVER: HIGH RISK PATIENTS AND TRANSPLANTATION CALCIUM
ANTAGONISTS: PHARMACOLOGY AND CLINICAL RESEARCH DRUGS
AFFECTING LIPID METABOLISM SEROTONIN
FROM CELL BIOLOGY TO PHARMACOLOGY AND THERAPEUTICS EVOLUZIONE
DEI CALCIO ANTAGONISTI: LA NUOVA GENERAZIONE ADEMETIONINA
PROFILO FARMACOLOGICO E CLINICO LOW
BLOOD CHOLESTEROL: HEALTH IMPLICATIONS
1994 THE
IMPACT OF BIOTECHNOLOGY ON AUTOIMMUNITY WOMEN'S
HEALTH IN MENOPAUSE - Behaviour, Cancer, Cardiovascular Disease,
Hormone Replacement Therapy DISLIPIDEMIA
DIABETICA ED ATEROSCLEROSI Highlights from the III International
Symposium on MULTIPLE RISK FACTORS IN CARDIOVASCULAR DISEASE Vascular
and Organ Protection (July 6-9, 1994). NEW
DIHYDROPYRIDINES IN VASCULAR PROTECTION Highlights from the III
International Symposium on MULTIPLE RISK FACTORS IN CARDIOVASCULAR DISEASE
Vascular and Organ Protection (July 6-9, 1994).
1995 FATTY
ACIDS AND LIPIDS: BIOLOGICAL ASPECTS ADVANCES
IN PROSTAGLANDINS, TROMBOXANE AND LEUKOTRIENE RESEARCH MULTIPLE
RISK FACTORS IN CARDIOVASCULAR DISEASE, VASCULAR AND ORGAN PROTECTION
PHARMACOLOGICAL
CONTROL OF CALCIUM AND POTASSIUM HOMEOSTASIS BEYOND
BLOOD PRESSURE: TISSUE PROTECTION BY CALCIUM ANTAGONISM CAN BE ENHANCED
BY ACE INHIBITION Highlights from the VI International Symposium
on PHARMACOLOGICAL CONTROL OF CALCIUM AND POTASSIUM HOMEOSTASIS Biological,
Therapeutical and Clinical Aspects (October 4-6, 1994). NEW
PERSPECTIVES ON ANTYMICOBACTERIAL DRUGS Highlights from the FIRST
EUROPEAN CONGRESS OF PHARMACOLOGY (June 16-19, 1995). PATHOPHYSIOLOGICAL
BASIS FOR THE TREATMENT OF DEMENTIA Highlights from the FIRST EUROPEAN
CONGRESS OF PHARMACOLOGY (June 16-19, 1995).
1996 DRUGS
AFFECTING LIPID METABOLISM - RISK FACTORS AND FUTURE DIRECTIONS
CONTINUING
MEDICAL CHALLENGES IN THE TREATMENT OF ATHEROSCLEROSIS: DEFINING THE
LIMITS OF THERAPY Highlights from the LXVI Congress of the EUROPEAN
ATHEROSCLEROSIS SOCIETY (July 13-17, 1996). DAL COLESTEROLO AGLI EVENTI CARDIOVASCOLARI: QUAL È IL LEGAME? Highlights from the LXVI Congress of the EUROPEAN ATHEROSCLEROSIS SOCIETY (July 13-17, 1996). Editors: M.R. Soma, A. Poli. Fondazione Giovanni Lorenzini, Milan, 1996, pp. 16. FROM CHOLESTEROL TO CARDIOVASCULAR EVENTS, WHERE IS THE BRIDGE? Highlights from the LXVI Congress of the EUROPEAN ATHEROSCLEROSIS SOCIETY (July 13-17, 1996). Editors: M.R. Soma, A. Poli. Fondazione Giovanni Lorenzini, Milan, 1996, pp. 16. NUOVI APPROCCI FARMACOLOGICI NEL CONTROLLO DELLE DISLIPIDEMIE Highlights from the LXVI Congress of the EUROPEAN ATHEROSCLEROSIS SOCIETY (July 13-17, 1996). Editors: A.L. Catapano, A. Poli. Fondazione Giovanni Lorenzini, Milan, 1996, pp. 20. EUROPEAN
POSITION PAPER ON HORMONE REPLACEMENT AND THE MENOPAUSE TERAPIA ORMONALE SOSTITUTIVA E PATOLOGIE CARDIOVASCOLARI Editors: P.G. Crosignani, M. Soma, R. Baetta. Fondazione Giovanni Lorenzini, Milan, 1996, pp. 28.
1997 DRUG
DEVELOPMENT RESEARCH Special Issue of the Purines '96: MOLECULAR
PHARMACOLOGICAL AND THERAPEUTIC ADVANCES CHOLESTEROL LOWERING AND CORONARY DISEASE: EVOLVING CONCEPTS Highlights from the LXVI Congress of the EUROPEAN ATHEROSCLEROSIS SOCIETY (July 13-17, 1996). Editors: P. Roma, A. Poli. Fondazione Giovanni Lorenzini, Milan, 1997, pp. 16. CLINICAL BENEFITS OF HMG-CoA REDUCTASE INHIBITORS: A CLOSER LOOK Highlights from the LXVI Congress of the EUROPEAN ATHEROSCLEROSIS SOCIETY (July 13-17, 1996). Editors: A. Poli, M.R. Soma. Fondazione Giovanni Lorenzini, Milan, 1997, pp. 20. NEW APPROACHES IN MANAGEMENT OF DYSLIPIDEMIA Highlights from the LXVI Congress of the EUROPEAN ATHEROSCLEROSIS SOCIETY (July 13-17, 1996). Editors: A.L. Catapano, A. Poli. Fondazione Giovanni Lorenzini, Milan, 1997, pp. 20. TRATTAMENTO DELL'ATEROSCLEROSI: OLTRE LA TERAPIA IPOLIPEMIZZANTE Highlights from the LXVI Congress of the EUROPEAN ATHEROSCLEROSIS SOCIETY (July 13-17, 1996). Editors: F. Bernini, A. Poli. Fondazione Giovanni Lorenzini, Milan, 1997, pp. 16. WOMEN'S HEALTH AND MENOPAUSE - RISK REDUCTION STRATEGIES Editors: R. Paoletti, P.G. Crosignani, P. Kenemans, G. Samsioe, M. Soma, A.S. Jackson. Kluwer Academic Publishers, Dordrecht, 1997, pp. 340. SICUREZZA
ED EFFICACIA DELLA HRT CON ESTROGENI NATURALI CONIUGATI (ENC) E MEDROSSIPROGESTERONE
ACETATO (MAP) Highlights from the II International Symposium on
WOMEN'S HEALTH AND MENOPAUSE - Risk Reduction Strategies (December 4-7,
1996). OSTEOPOROSI POSTMENOPAUSALE E TERAPIA ORMONALE SOSTITUTIVA Editors: P.G._Crosignani, F. Bruschi, M. Meschia. Fondazione Giovanni Lorenzini, Milan, 1997, pp. 20. HORMONE REPLACEMENT AND THE MENOPAUSE: A EUROPEAN POSITION PAPER P.G._Crosignani, P._Kenemans, R._Paoletti, M.R._Soma, F.P._Woodford. European Journal of Obstetrics & Gynecology and Reproductive Biology, Elsevier Science Ireland Ltd., 1997, vol._74, pp. 67-72. COLESTEROLO
E MALATTIA CORONARICA: DALLE IPOTESI ALLE CERTEZZE Highlights.
1998 CHALLENGES
AND OPPORTUNITIES IN LIPID LOWERING THERAPY Highlights from the
XIII_International Symposium on "DRUGS AFFECTING LIPID METABOLISM" (May
30 - June 3, 1998) HDL AND CARDIOVASCULAR RISK: NEW INSIGHTS Highlights from the XIII_International Symposium on "DRUGS AFFECTING LIPID METABOLISM" (May 30 - June 3, 1998) Editors: A.L. Catapano, A._Faggiotto, A. Poli. Fondazione Giovanni Lorenzini, Milan, 1998, pp. 20. MODIFYING
PLASMA LIPOPROTEIN LEVELS FOR THERAPEUTIC BENEFIT Highlights from
the XIII_International Symposium on "DRUGS AFFECTING LIPID METABOLISM"
(May 30 - June 3, 1998) DIRECT
ANTIATHEROSCLEROTIC EFFECTS OF STATINS: FROM EXPERIMENTAL EVIDENCE TO
CLINICAL BENEFIT Highlights from the XIII_International Symposium
on "DRUGS AFFECTING LIPID METABOLISM" (May 30 - June 3, 1998) UNLOCKING THE COMPLEXITY OF ATHEROSCLEROSIS Highlights from the XIII_International Symposium on "DRUGS AFFECTING LIPID METABOLISM" (May 30 - June 3, 1998) Editors: A.L. Catapano, A._Faggiotto, A. Poli. Fondazione Giovanni Lorenzini, Milan, 1998, pp. 20. MODIFICARE
I LIVELLI DELLE LIPOPROTEINE PLASMATICHE PER OTTENERE BENEFICI TERAPEUTICI
Highlights from the XIII_International Symposium on "DRUGS AFFECTING
LIPID METABOLISM" (May 30 - June 3, 1998)
1999 WOMEN'S
HEALTH AND MENOPAUSE RISK REDUCTION STRATEGIES-IMPROVED QUALITY OF HEALTH MEETING INTERNAZIONALE "CREATINA: DALLA SCIENZA DI BASE ALL'APPLICAZIONE CLINICA". Highlights Editors: A. Poli . Fondazione Giovanni Lorenzini, Milan, 1999, pp. 32 SIMPOSIO
INTERNAZIONALE "CONSUMO MODERATO DI ALCOOL E MALATTIE CARDIOVASCOLARI"
IL
RUOLO DELLE STATINE NEL NUOVO MILLENNIO PLASMA
LIPIDS AND DIABETES CREATINA: DALLA SCIENZA DI BASE
ALL’APPLICAZIONE CLINICA CONSUMO MODERATO DI ALCOOL E MALATTIE CARDIOVASCOLARI
2000 Abstracts of the "XIII CONGRESS OF THE ITALIAN SOCIETY FOR THE STUDY OF ATHEROSCLEROSIS" Supplement Atherosclerosis. Vol. 151 Suppl. 1, S1-S38 (2000) IL
RUOLO DELL'INTEGRAZIONE NUTRIZIONALE NEL SOGGETTO ANZIANO CREATINE
- FROM BASIC SCIENCE TO CLINICAL APPLICATION MODERATE
ALCOHOL CONSUMPTION AND CARDIOVASCULAR DISEASE NEW
ANTI-INFLAMMATORY AGENTS: NO-NSAIDs AND COX-2 INHIBITORS
2001
2002 ADVANCES
IN PROSTAGLANDIN AND LEUKOTRIENE RESEARCH: Basic Science and New Clinical
Applications PPARs:
From Basic Science to Clinical Application WOMEN’S
HEALTH AND MENOPAUSE
CD-ROM INTERNATIONAL
POSITION PAPER ON WOMEN’S HEALTH AND MENOPAUSE: A COMPREHENSIVE
APPROACH CD-ROM |